Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients

NCT02246920 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1474

Enrollment

INDUSTRY

Sponsor class

Stopped Development Halted

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Fluticasone propionate
DRUG: Flonase®
DRUG: Placebo

Sponsor

Teva Pharmaceuticals USA